Prevalence of peripheral neuropathy in newly diagnosed type 2 diabetics in sub-district hospital Bishnah
DOI:
https://doi.org/10.18203/2349-3933.ijam20211916Keywords:
Peripheral neuropathy, Type 2 diabetes mellitus, Neuropathy symptoms score, Neuropathy disability scoreAbstract
Background: Diabetic neuropathy is a loss of sensory function beginning distally in the lower extremities that is also characterized by pain and substantial morbidity. Screening and early identification of neuropathy among diabetics can be a crucial opportunity for course modulation for keeping the glycemic control to optimal levels and within recommended targets.
Methods: A cross sectional observational study were conducted on 100 patients older than 30 years, of newly diagnosed type 2 diabetes mellitus (T2DM) and attending medicine OPD of sub district hospital Bishnah, district Jammu, Jammu and Kashmir from April 2020 to January 2021. Diabetic peripheral neuropathy (DPN) was diagnosed if two or more of the abnormalities of neuropathy symptoms score or neuropathy disability score were present.
Results: Among the studied subjects, 59% were males and 41% were females. Mean age was 49.22±10.63 years for diabetics. 29% patients were alcoholic and 24% were smokers and body mass index (BMI) of more than 25 was found in 20% of patients. Most common of symptoms was tingling (37.14%). 29 subjects had neuropathic signs and neuropathy disability score (NDS) more than or equal to 2 with 28 of them having reduced nerve conduction velocity and loss of vibration in 65.52% patients. A higher prevalence of DPN was found among DM duration of greater than 5 years.
Conclusions: The present study showed a significant correlation between DPN, duration of diabetes and BMI. Detection of neuropathic symptoms and complications is therefore essential among patients with T2DM before it hampers their quality of life.
Metrics
References
Skoner DP. Allergic rhinitis: Definition, epidemiology, pathology, detection and diagnosis. Allergy Clin Immunol. 2001;108:2-8.
Leow SK, Griva K, Choo R, Wee LH, Tai SE, Newmann S. Determinants of health related quality of life in the multiethnic Singapore population-a national cohort study. Plos One. 2013;8(6):67138.
India State-Level Disease Burden Initiative Diabetes Collaborators. The increasing burden of diabetes and variations among the states of India: the global burden of disease study 1990-2016. Lancet Glob Health. 2018;6(12):1352-62.
Jayaprakash P, Bhansali A, Bhansali S, Dutta P, Anantharaman R, Shanmugasundar G, et al. Validation of bedside methods in evaluation of diabetic peripheral neuropathy. Indian J Med Res. 2011;133(6):645-9.
Dyck PJ, Sherman WR, Hallcher LM, Service FJ, O’Brien PC, Grina LA, et al. Human diabetic endoneurol sorbitol, fructose and myoinositol related to sural nerve morphometry. Ann Neurol. 1980;8:590-6.
Dyck PJ, Karnes JI, Daube J, O’Brien P, Service FJ. Clinical and neurological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain. 1985;108:861-80.
Barrett EJ, Liu Z, Khamaisi M, King GL, Klein R, Klein BEK, et al. Diabetic microvascular disease: an endocrine society scientific statement. J Clin Endocrinol Metab. 2017;102(12):4343-410.
Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF. Sensory neuropathy in non-insulin dependent diabetes mellitus. The San Luis Valley Diabetes Study. Am J Epidemiol. 1990;131(4):633-43
Nielsen JV. Peripheral neuropathy, hypertension, foot ulcers and amputations among Saudi-Arabian patients with type 2 diabetes. Diabetes Res Clin Pract. 1998;41(1):63-9.
Sun J, Wang Y, Zhang X, Zhu S, He H. Prevalence of peripheral neuropathy in patients with diabetes: a systematic review and meta-analysis. Prim Care Diabetes. 2020;14(5):435-44.
Sendi RA, Mahrus AM, Saeed RM, Mohammed MA, Al-Dubai SAR. Diabetic peripheral neuropathy among Saudi diabetic patients: a multicenter cross-sectional study at primary health care setting. J Family Med Prim Care. 2020;9(1):197-201.
Braffett BH, Gubitosi-Klug RA, Albers JW, Feldman EL, Martin CL, White NH, et al. Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes. 2020;69(5):1000-10.
Shiferaw WS, Akalu TY, Work Y, Aynalem YA. Prevalence of diabetic peripheral neuropathy in Africa: a systematic review and meta-analysis. BMC Endocr Disord. 2020;20(1):49.
Yang Q, Zhang Y, Zeng Q, Yang C, Shi J, Zhang C, et al. Correlation Between diabetic peripheral neuropathy and sarcopenia in patients with type 2 diabetes mellitus and diabetic foot disease: a cross-sectional study. Diabetes Metab Syndr Obes. 2020;13:377-86.
Qin L, Niu JY, Zhou JY, Zhang QJ, Zhou F, Zhang N, et al. Prevalence and risk factors of diabetic peripheral neuropathy in Chinese communities. Zhonghua Liu Xing Bing Xue Za Zhi. 2019;40(12):1578-84.
Perrin BM, Allen P, Gardner MJ, Chappell A, Phillips B, Massey C, et al. The foot-health of people with diabetes in regional and rural Australia: baseline results from an observational cohort study. J Foot Ankle Res. 2019;12:56.
Ratzmann KP, Rashke M, Gander I, Schimke E. Prevalence of peripheral and autonomic neuropathy in newly diagnosed type 2, non-insulin dependent diabetes. J Diabet Complicat. 1991;5:1-5
Ashok S, Ramu M, Deepa R, Mohan V. Prevalence of neuropathy in type 2 diabetic patients attending a diabetes centre in South India. JAPI. 2002;50:546-50.
Kluding PM, Pasnoor M, Singh R, Jernigan S, Farmer K, Rucker J, et al.The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabet Complicat. 2012;26(5):424-9.
AlMaskari F. Prevalence and determinants of peripheral neuropathy in patients with type 2 diabetes attending a tertiary care center in the United Arab Emirates. J Diabet Metabol. 2014;5(346):2.
Devi HSM, Prasad RV, Bazroy J, Singh Z. Prevalence and determinants of peripheral neuropathy among diabetics in a rural cum costal area of Villupuram district, Tamil Nadu. International J Res Med Sci. 2015;3(10):2567-71.
Edwards JL, Vincent A, Cheng T, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther. 2014;120(1):1-34.
Vander-Velde JHPM, Koster A, Strotmeyer ES, Mess WH, Hilkman D, Reulen JPH, et al. Cardiometabolic risk factors as determinants of peripheral nerve function: the Maastricht Study. Diabetologia. 2020;63(8):1648-58.
D’Souza M, Kulkarni V, Bhaskaran U, Ahmed H, Naimish H, Prakash A, et al. Diabetic peripheral neuropathy and its determinants among patients attending a tertiary health care centre in Mangalore, India. J Pub Health Res. 2015;4(2):450.
Clair C, Cohen MJ, Eichler F, Selby KJ, Rigotti NA. The effect of cigarette smoking on diabetic peripheral neuropathy: a systematic review and meta-analysis. J Gen Intern Med. 2015;30(8):1193-203.
Downloads
Published
How to Cite
Issue
Section
